Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Johan M.S. van der Schoot"'
Autor:
Luis J. Cruz, Paul J. Tacken, Johan M.S. van der Schoot, Felix Rueda, Ruurd Torensma, Carl G. Figdor
Publikováno v:
Molecules, Vol 24, Iss 9, p 1825 (2019)
Optimal targeting of nanoparticles (NP) to dendritic cells (DCs) receptors to deliver cancer-specific antigens is key to the efficient induction of anti-tumour immune responses. Poly (lactic-co-glycolic acid) (PLGA) nanoparticles containing tètanus
Externí odkaz:
https://doaj.org/article/a9eca1d4e4d947dc8fb7c9ce59425137
Autor:
Kimberly M. Bonger, Camille M. Le Gall, Melek Parlak Khalily, Martijn Verdoes, Iván Ramos-Tomillero, Liyan Smeding, Carl G. Figdor, Johan M.S. van der Schoot, Anna Cammarata, Zacharias Wijfjes, Ferenc A. Scheeren, Floris J. van Dalen, Duco van Dalen
Publikováno v:
Bioconjugate Chemistry
Bioconjugate Chemistry, 32(2), 301-310. AMER CHEMICAL SOC
Bioconjugate Chemistry, 32, 2, pp. 301-310
Bioconjugate Chemistry, 32, 301-310
bioRxiv
Bioconjugate Chemistry, 32(2), 301-310. AMER CHEMICAL SOC
Bioconjugate Chemistry, 32, 2, pp. 301-310
Bioconjugate Chemistry, 32, 301-310
bioRxiv
I.AbstractFunctionalized antibodies and antibody fragments have found applications in the fields of biomedical imaging, theragnostics, and antibody-drug conjugates (ADC). Antibody functionalization is classically achieved by coupling payloads onto ly
Autor:
Felix Rueda, Ruurd Torensma, Paul J. Tacken, Carl G. Figdor, Johan M.S. van der Schoot, Luis J. Cruz
Publikováno v:
Molecules, 24, 9
Molecules
Volume 24
Issue 9
Molecules, 24(9)
Molecules, Vol 24, Iss 9, p 1825 (2019)
Molecules, 24
Molecules
Volume 24
Issue 9
Molecules, 24(9)
Molecules, Vol 24, Iss 9, p 1825 (2019)
Molecules, 24
Optimal targeting of nanoparticles (NP) to dendritic cells (DCs) receptors to deliver cancer-specific antigens is key to the efficient induction of anti-tumour immune responses. Poly (lactic-co-glycolic acid) (PLGA) nanoparticles containing tè<
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0f4d3847edb6bd1158cd99e9b84f926
https://doi.org/10.3390/molecules24091825
https://doi.org/10.3390/molecules24091825
Autor:
Duco van Dalen, Camille M. Le Gall, Tomislav Čaval, Johan M.S. van der Schoot, Anouk M. D. Becker, Michael Valente, J. Armando C. van Bruggen, Ferenc A. Scheeren, Carl G. Figdor, Marieke F. Fransen, Yusuf Dolen, Martijn Verdoes, Iris M. Hagemans, Maaike Nederend, Gestur Vidarsson, Jeanette H. W. Leusen, Albert J. R. Heck, Felix L. Fennemann, Arthur E. H. Bentlage, Melanie Engelfriet, Alper Cevirgel
Publikováno v:
bioRxiv
Hybridoma technology is instrumental for the development of novel antibody therapeutics and diagnostics. Recent preclinical and clinical studies highlight the importance of antibody isotype for therapeutic efficacy. However, since the sequence encodi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90310b3ac8f789fea72911dd3d9ee2b0